000869:SZSEYantai Changyu Pioneer Wine Company Limited Analysis
Data as of 2026-05-27 - not real-time
CN¥18.12
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Yantai Changyu Pioneer Wine (000869.SZ) is trading at CNY 18.12, below its 20‑day (19.06) and 50‑day (19.20) simple moving averages, signaling a bearish price trend. The 14‑day RSI of 25.6 places the stock in oversold territory, while the MACD histogram remains negative, reinforcing short‑term downside pressure. Support sits near CNY 17.85 and resistance around CNY 19.54, with volume trending higher, suggesting a potential bounce off the support level. Valuation metrics are mixed: a trailing PE of 181 is dramatically high, yet the forward PE of 19.3 and a DCF‑derived fair value of CNY 17.88 imply the market may be pricing in modest earnings growth. The dividend yield of 2.21 % with a payout ratio of only 4 % underscores a highly sustainable payout.
Fundamentally, the company generates solid cash – CNY 5.18 bn operating cash flow and CNY 5.45 bn free cash flow – and holds a net cash position of over CNY 2 bn, offsetting a high debt‑to‑equity ratio of 3.99. Profitability, however, is thin (net margin 1.98 %) and returns are weak (ROE 0.57 %). The consumer‑defensive wine sector provides a stable demand backdrop, and the stock’s beta of 0.20 indicates low market sensitivity. Given the modest revenue growth (8.3 %) and the attractive dividend, the equity appears fairly valued with a slight upside to its DCF target. Investors should weigh the low growth and thin margins against the strong cash generation and defensive positioning.
Fundamentally, the company generates solid cash – CNY 5.18 bn operating cash flow and CNY 5.45 bn free cash flow – and holds a net cash position of over CNY 2 bn, offsetting a high debt‑to‑equity ratio of 3.99. Profitability, however, is thin (net margin 1.98 %) and returns are weak (ROE 0.57 %). The consumer‑defensive wine sector provides a stable demand backdrop, and the stock’s beta of 0.20 indicates low market sensitivity. Given the modest revenue growth (8.3 %) and the attractive dividend, the equity appears fairly valued with a slight upside to its DCF target. Investors should weigh the low growth and thin margins against the strong cash generation and defensive positioning.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- RSI at 25.6 indicates oversold conditions
- Price below 20‑day and 50‑day SMAs
- Increasing volume suggests potential support bounce
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- Forward PE of 19.3 signals reasonable valuation
- Dividend yield of 2.21% with low payout ratio
- Strong cash generation and net cash position
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Consumer‑defensive sector provides stability
- Low beta (0.20) indicates limited market volatility
- Thin profit margins and low ROE limit upside
Key Metrics & Analysis
Financial Health
Revenue Growth8.30%
Profit Margin1.98%
P/E Ratio181.2
ROE0.57%
ROA0.59%
Debt/Equity3.99
P/B Ratio1.2
Op. Cash FlowCN¥518.4M
Free Cash FlowCN¥545.2M
Technical Analysis
TrendBearish
RSI25.6
SupportCN¥17.85
ResistanceCN¥19.54
MA 20CN¥19.06
MA 50CN¥19.20
MA 200CN¥20.79
MACDBearish
VolumeIncreasing
Fear & Greed Index91.91
Valuation
Fair ValueCN¥17.88
GradeFair
TypeBlend
Dividend Yield2.21%
Risk Assessment
Beta0.20
Volatility12.45%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.